Financials data is unavailable for this security.
View more
Year on year BioLife Solutions Inc has grown net income from a loss of -139.81m to a smaller loss of -66.43m despite falling revenues.
Gross margin | 41.27% |
---|---|
Net profit margin | -44.46% |
Operating margin | -40.35% |
Return on assets | -13.33% |
---|---|
Return on equity | -16.00% |
Return on investment | -14.60% |
More ▼
Cash flow in USDView more
In 2023, BioLife Solutions Inc increased its cash reserves by 81.99%, or 15.97m. Cash Flow from Investing totalled 17.84m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 12.50m for operations while cash generated from financing totalled 10.59m.
Cash flow per share | -0.9668 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 6.97 |
---|---|
Tangible book value per share | 1.68 |
More ▼
Balance sheet in USDView more
Current ratio | 2.86 |
---|---|
Quick ratio | 1.81 |
Total debt/total equity | 0.0696 |
---|---|
Total debt/total capital | 0.0651 |
More ▼